TNFRSF10A and cancer: Furthermore, in contrast to DR5, altering the N-glycosylation site in DR4 could also lead to a reduction in overall sensitivity of the cancer cells and CSCs to TRAIL by decreasing TRAIL receptor aggregation and DISC (death inducing signaling complex) formation [101].